September 25, 2017
College Park Marriott / Hyattsville, MD

Through the Patient-Focused Drug Development (PFDD) meeting, the patients and caregivers are provided a platform to communicate the patient’s perspective on available/current treatments, share our stories, and provide an insight on treatments vs. symptoms. Bringing our patient and caregiver voice to drug/therapy development is a milestone, because it is a direct path to understanding and acknowledging how lupus affects people on a day-to-day basis and the urgency for better treatments.

Elizabeth SantaCruz
Mother of child with lupus